United States President Donald Trump has confirmed that his proposed 25-percent tariffs on Mexican and Canadian goods will take effect on March 4, alongside an additional 10-percent tariff on Chinese imports, citing ongoing concerns about deadly drugs flowing into the US.
In a statement posted on Truth Social on Thursday, Trump asserted that the new 10-percent tariff on Chinese goods would be added to an existing 10-percent duty imposed on February 4 in response to the fentanyl crisis. Trump claimed that despite previous measures, dangerous drugs — particularly fentanyl — were still entering the US at “very high and unacceptable levels.”
“We cannot allow this scourge to continue to harm the USA, and therefore, until it stops, or is seriously limited, the proposed TARIFFS scheduled to go into effect on MARCH FOURTH will, indeed, go into effect, as scheduled,” Trump wrote. “China will likewise be charged an additional 10% Tariff on that date.”
Clearing Up Confusion Over Tariff Deadlines
Trump’s statement clarified uncertainty created during a cabinet meeting on Wednesday, where he suggested the deadline might be pushed back to April 4. However, White House officials later explained that the April date pertains to Trump’s planned “reciprocal tariffs”, designed to match import duties and offset trade restrictions imposed by other nations — particularly in Europe.
Kevin Hassett, Trump’s chief economic adviser, told CNBC that the reciprocal tariff policy would be decided after a trade study concludes on April 1.
Meanwhile, a White House official told Reuters that Trump decided to stick to the March 4 deadline for tariffs on Canada, Mexico, and China, due to what his administration views as insufficient progress in addressing fentanyl-related deaths.
“There are ongoing discussions with the Chinese, Mexico, and Canada. We’ve gotten a good handle on the migration issue, but there are still concerns on the other issue of fentanyl deaths,” the official said.
Fentanyl Crisis Driving Tariff Decisions
The Centers for Disease Control and Prevention (CDC) reported that 72,776 Americans died from synthetic opioids in 2023, with fentanyl as the primary cause. The Trump administration argues that stronger trade penalties are necessary to pressure foreign governments into tackling drug smuggling more aggressively.
As the March 4 deadline approaches, Trump’s decision is likely to escalate tensions with major trading partners and intensify the ongoing debate over how best to address both the opioid crisis and global trade imbalances.
